Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ELCC 2017
The 7th European Lung Cancer Conference
Access to all presentations that took place at ELCC 2017 in Geneva, Switzerland
Presentation Date(s):- May 5 – 8, 2017
- Total Presentations: 359
-
+
Should we use newer generation targeted treatment upfront?
- Type: Controversy session
- Presentations: 4
- Moderators:E. Smit
- Coordinates: 5/06/2017, 09:15 - 10:15, Room A
-
+
Introduction and first vote
09:15 - 09:25 | Author(s): T.S.K. Mok
- Abstract
No abstract available for this presentation
-
+
Yes
09:25 - 09:45 | Author(s): D.P. Carbone
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
No
09:45 - 10:05 | Author(s): F. Barlesi
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Second vote and conclusions
10:05 - 10:15 | Author(s): E. Smit
- Abstract
No abstract available for this presentation
-
+
Liquid biopsies in NSCLC
- Type: Educational session
- Presentations: 5
- Moderators:H. Wikman-Kocher
- Coordinates: 5/06/2017, 14:45 - 16:15, Room A
-
+
Role of cfDNA to monitor EGFR dynamic changes and resistance in blood
15:30 - 15:45 | Author(s): T.S.K. Mok
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Poster Display Session
- Type: Poster Display Session
- Presentations: 142
- Coordinates: 5/07/2017, 12:30 - 13:00, Hall 1
-
+
58TiP - IMpower133: Phase I/III trial of first-line atezolizumab with carboplatin and etoposide in ES-SCLC
12:30 - 12:30 | Author(s): M. Reck
- Abstract
Loading... -
+
146TiP - EXalt3: A phase III study of ensartinib (X-396) in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC)
12:30 - 12:30 | Author(s): L. Horn
- Abstract
Loading...